10,194 results on '"antilymphocyte serum"'
Search Results
2. Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
3. Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation (CY-MET-RIC)
4. Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults
5. Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
6. Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
7. Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies
8. Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia (REACTS)
9. Precision Administration of Anti-thymocyte Globulin With or Without Verapamil
10. STOP-T1D Low-Dose (ATG) (TN28)
11. Haploidentical HCT for Severe Aplastic Anemia
12. Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
13. Treg Modulation With CD28 and IL-6 Receptor Antagonists
14. Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
15. Advancing Transplantation Outcomes in Children (ADVANTage)
16. Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation
17. Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
18. Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
19. Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) (STRIDE2)
20. Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.
21. A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
22. Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation
23. MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs
24. Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
25. A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) (TransIT)
26. Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
27. Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis (SSc)
28. Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
29. Thymus Transplantation Safety-Efficacy
30. A Study of TCD601 in de Novo Renal Transplant Recipients (ASCEND)
31. Expanded Access Protocol Thymus Transplantation
32. Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
33. A Phase II Pediatric Study of a Graft-VS.-Host Disease (GVHD) Prophylaxis Regimen With no Calcineurin Inhibitors After Day +60 Post First Allogeneic Hematopoietic Cell Transplant for Hematological Malignancies
34. BIVV020 (SAR445088) n Prevention and Treatment of Antibody-mediated Rejection (AMR)
35. TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)
36. CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies
37. Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
38. Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
39. Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)
40. Personalized NK Cell Therapy in CBT
41. Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
42. Diabetes Islet Preservation Immune Treatment (DIPIT)
43. Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
44. Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML (ABCD-NK)
45. Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases
46. Stem Cell Transplantation in Crohn's Disease
47. Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
48. RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT
49. Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors
50. Biochemical Correction of Severe EB by Allo HSCT and 'Off-the-shelf' MSCs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.